Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

A transgenic mouse model reproduces human hereditary systemic amyloidosis.

Chabert M, Rousset X, Colombat M, Lacasa M, Kakanakou H, Bourderioux M, Brousset P, Burlet-Schiltz O, Liepnieks JJ, Kluve-Beckerman B, Lambert G, Châtelet FP, Benson MD, Kalopissis AD.

Kidney Int. 2019 Mar 28. pii: S0085-2538(19)30338-2. doi: 10.1016/j.kint.2019.03.013. [Epub ahead of print]

PMID:
31200944
2.

Proteomics evidence of specific IGKV1-8 association with cystic lung light chain deposition disease.

Camus M, Hirschi S, Prevot G, Chenard MP, Mal H, Stern M, Reynaud-Gaubert M, Gilhodes J, Burlet-Schiltz O, Brousset P, Colombat M.

Blood. 2019 Apr 9. pii: blood.2019898577. doi: 10.1182/blood.2019898577. [Epub ahead of print]

PMID:
30967366
3.

Analysis of durum wheat proteome changes under marine and fungal biostimulant treatments using large-scale quantitative proteomics: A useful dataset of durum wheat proteins.

Pichereaux C, Laurent EA, Gargaros A, Viudes S, Durieu C, Lamaze T, Grieu P, Burlet-Schiltz O.

J Proteomics. 2019 May 30;200:28-39. doi: 10.1016/j.jprot.2019.03.003. Epub 2019 Mar 9.

PMID:
30862563
4.

Mass Spectrometry-based Absolute Quantification of 20S Proteasome Status for Controlled Ex-vivo Expansion of Human Adipose-derived Mesenchymal Stromal/Stem Cells.

Menneteau T, Fabre B, Garrigues L, Stella A, Zivkovic D, Roux-Dalvai F, Mouton-Barbosa E, Beau M, Renoud ML, Amalric F, Sensébé L, Gonzalez-de-Peredo A, Ader I, Burlet-Schiltz O, Bousquet MP.

Mol Cell Proteomics. 2019 Apr;18(4):744-759. doi: 10.1074/mcp.RA118.000958. Epub 2019 Jan 30.

5.

Muscle wasting in patients with end-stage renal disease or early-stage lung cancer: common mechanisms at work.

Aniort J, Stella A, Philipponnet C, Poyet A, Polge C, Claustre A, Combaret L, Béchet D, Attaix D, Boisgard S, Filaire M, Rosset E, Burlet-Schiltz O, Heng AE, Taillandier D.

J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):323-337. doi: 10.1002/jcsm.12376. Epub 2019 Jan 29.

6.

VisioProt-MS: interactive 2D maps from intact protein mass spectrometry.

Locard-Paulet M, Parra J, Albigot R, Mouton-Barbosa E, Bardi L, Burlet-Schiltz O, Marcoux J.

Bioinformatics. 2019 Feb 15;35(4):679-681. doi: 10.1093/bioinformatics/bty680.

7.

Small molecule-based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy.

Gervais V, Muller I, Mari PO, Mourcet A, Movellan KT, Ramos P, Marcoux J, Guillet V, Javaid S, Burlet-Schiltz O, Czaplicki G, Milon A, Giglia-Mari G.

J Biol Chem. 2018 Sep 28;293(39):14974-14988. doi: 10.1074/jbc.RA118.003444. Epub 2018 Aug 1.

PMID:
30068551
8.

The exerkine apelin reverses age-associated sarcopenia.

Vinel C, Lukjanenko L, Batut A, Deleruyelle S, Pradère JP, Le Gonidec S, Dortignac A, Geoffre N, Pereira O, Karaz S, Lee U, Camus M, Chaoui K, Mouisel E, Bigot A, Mouly V, Vigneau M, Pagano AF, Chopard A, Pillard F, Guyonnet S, Cesari M, Burlet-Schiltz O, Pahor M, Feige JN, Vellas B, Valet P, Dray C.

Nat Med. 2018 Sep;24(9):1360-1371. doi: 10.1038/s41591-018-0131-6. Epub 2018 Jul 30.

PMID:
30061698
9.

The costimulatory molecule CD226 signals through VAV1 to amplify TCR signals and promote IL-17 production by CD4+ T cells.

Gaud G, Roncagalli R, Chaoui K, Bernard I, Familiades J, Colacios C, Kassem S, Monsarrat B, Burlet-Schiltz O, de Peredo AG, Malissen B, Saoudi A.

Sci Signal. 2018 Jul 10;11(538). pii: eaar3083. doi: 10.1126/scisignal.aar3083.

PMID:
29991650
10.

PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.

Jonik-Nowak B, Menneteau T, Fesquet D, Baldin V, Bonne-Andrea C, Méchali F, Fabre B, Boisguerin P, de Rossi S, Henriquet C, Pugnière M, Ducoux-Petit M, Burlet-Schiltz O, Lamond AI, Fort P, Boulon S, Bousquet MP, Coux O.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6477-E6486. doi: 10.1073/pnas.1722299115. Epub 2018 Jun 22.

11.

Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease.

Denadai-Souza A, Bonnart C, Tapias NS, Marcellin M, Gilmore B, Alric L, Bonnet D, Burlet-Schiltz O, Hollenberg MD, Vergnolle N, Deraison C.

Sci Rep. 2018 May 18;8(1):7834. doi: 10.1038/s41598-018-26282-y.

12.

HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness.

Lefebvre C, Boulon R, Ducoux M, Gavalda S, Laval F, Jamet S, Eynard N, Lemassu A, Cam K, Bousquet MP, Bardou F, Burlet-Schiltz O, Daffé M, Quémard A.

Sci Rep. 2018 Apr 16;8(1):6034. doi: 10.1038/s41598-018-24380-5.

13.

Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33.

Cayrol C, Duval A, Schmitt P, Roga S, Camus M, Stella A, Burlet-Schiltz O, Gonzalez-de-Peredo A, Girard JP.

Nat Immunol. 2018 Apr;19(4):375-385. doi: 10.1038/s41590-018-0067-5. Epub 2018 Mar 19.

PMID:
29556000
14.

Asb2α-Filamin A Axis Is Essential for Actin Cytoskeleton Remodeling During Heart Development.

Métais A, Lamsoul I, Melet A, Uttenweiler-Joseph S, Poincloux R, Stefanovic S, Valière A, Gonzalez de Peredo A, Stella A, Burlet-Schiltz O, Zaffran S, Lutz PG, Moog-Lutz C.

Circ Res. 2018 Mar 16;122(6):e34-e48. doi: 10.1161/CIRCRESAHA.117.312015. Epub 2018 Jan 26.

PMID:
29374072
15.

Metabolome and proteome changes between biofilm and planktonic phenotypes of the marine bacterium Pseudoalteromonas lipolytica TC8.

Favre L, Ortalo-Magné A, Pichereaux C, Gargaros A, Burlet-Schiltz O, Cotelle V, Culioli G.

Biofouling. 2018 Feb;34(2):132-148. doi: 10.1080/08927014.2017.1413551. Epub 2018 Jan 10.

PMID:
29319346
16.

Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane.

Chiaradia L, Lefebvre C, Parra J, Marcoux J, Burlet-Schiltz O, Etienne G, Tropis M, Daffé M.

Sci Rep. 2017 Oct 9;7(1):12807. doi: 10.1038/s41598-017-12718-4.

17.

Protein O-mannosylation deficiency increases LprG-associated lipoarabinomannan release by Mycobacterium tuberculosis and enhances the TLR2-associated inflammatory response.

Alonso H, Parra J, Malaga W, Payros D, Liu CF, Berrone C, Robert C, Meunier E, Burlet-Schiltz O, Rivière M, Guilhot C.

Sci Rep. 2017 Aug 11;7(1):7913. doi: 10.1038/s41598-017-08489-7.

18.

Control of RUNX-induced repression of Notch signaling by MLF and its partner DnaJ-1 during Drosophila hematopoiesis.

Miller M, Chen A, Gobert V, Augé B, Beau M, Burlet-Schiltz O, Haenlin M, Waltzer L.

PLoS Genet. 2017 Jul 25;13(7):e1006932. doi: 10.1371/journal.pgen.1006932. eCollection 2017 Jul.

19.

Identification of specific posttranslational O-mycoloylations mediating protein targeting to the mycomembrane.

Carel C, Marcoux J, Réat V, Parra J, Latgé G, Laval F, Demange P, Burlet-Schiltz O, Milon A, Daffé M, Tropis MG, Renault MAM.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4231-4236. doi: 10.1073/pnas.1617888114. Epub 2017 Apr 3.

20.

Proteomic Analysis of Regulatory T Cells Reveals the Importance of Themis1 in the Control of Their Suppressive Function.

Duguet F, Locard-Paulet M, Marcellin M, Chaoui K, Bernard I, Andreoletti O, Lesourne R, Burlet-Schiltz O, Gonzalez de Peredo A, Saoudi A.

Mol Cell Proteomics. 2017 Aug;16(8):1416-1432. doi: 10.1074/mcp.M116.062745. Epub 2017 Apr 3.

21.

Scrutiny of Mycobacterium tuberculosis 19 kDa antigen proteoforms provides new insights in the lipoglycoprotein biogenesis paradigm.

Parra J, Marcoux J, Poncin I, Canaan S, Herrmann JL, Nigou J, Burlet-Schiltz O, Rivière M.

Sci Rep. 2017 Mar 8;7:43682. doi: 10.1038/srep43682.

22.

CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Dozier C, Mazzolini L, Cénac C, Froment C, Burlet-Schiltz O, Besson A, Manenti S.

Oncogene. 2017 Jun 29;36(26):3781-3788. doi: 10.1038/onc.2016.506. Epub 2017 Feb 13.

PMID:
28192398
23.

Mechanistic insights into the impact of Cold Atmospheric Pressure Plasma on human epithelial cell lines.

Dezest M, Chavatte L, Bourdens M, Quinton D, Camus M, Garrigues L, Descargues P, Arbault S, Burlet-Schiltz O, Casteilla L, Clément F, Planat V, Bulteau AL.

Sci Rep. 2017 Jan 25;7:41163. doi: 10.1038/srep41163.

24.

The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors.

Chantalat E, Boudou F, Laurell H, Palierne G, Houtman R, Melchers D, Rochaix P, Filleron T, Stella A, Burlet-Schiltz O, Brouchet A, Flouriot G, Métivier R, Arnal JF, Fontaine C, Lenfant F.

Breast Cancer Res. 2016 Dec 7;18(1):123.

25.

Looking for Missing Proteins in the Proteome of Human Spermatozoa: An Update.

Vandenbrouck Y, Lane L, Carapito C, Duek P, Rondel K, Bruley C, Macron C, Gonzalez de Peredo A, Couté Y, Chaoui K, Com E, Gateau A, Hesse AM, Marcellin M, Méar L, Mouton-Barbosa E, Robin T, Burlet-Schiltz O, Cianferani S, Ferro M, Fréour T, Lindskog C, Garin J, Pineau C.

J Proteome Res. 2016 Nov 4;15(11):3998-4019. Epub 2016 Aug 23.

PMID:
27444420
26.

Deimination of Human Hornerin Enhances its Processing by Calpain-1 and its Cross-Linking by Transglutaminases.

Hsu CY, Gasc G, Raymond AA, Burlet-Schiltz O, Takahara H, Serre G, Méchin MC, Simon M.

J Invest Dermatol. 2017 Feb;137(2):422-429. doi: 10.1016/j.jid.2016.09.030. Epub 2016 Oct 11.

27.

Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics.

Matondo M, Marcellin M, Chaoui K, Bousquet-Dubouch MP, Gonzalez-de-Peredo A, Monsarrat B, Burlet-Schiltz O.

Proteomics. 2017 Apr;17(7). doi: 10.1002/pmic.201600089. Epub 2016 Dec 21.

28.

Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells.

Gautier V, Cayrol C, Farache D, Roga S, Monsarrat B, Burlet-Schiltz O, Gonzalez de Peredo A, Girard JP.

Sci Rep. 2016 Oct 3;6:34255. doi: 10.1038/srep34255.

29.

Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis.

Le NH, Molle V, Eynard N, Miras M, Stella A, Bardou F, Galandrin S, Guillet V, André-Leroux G, Bellinzoni M, Alzari P, Mourey L, Burlet-Schiltz O, Daffé M, Marrakchi H.

J Biol Chem. 2016 Oct 21;291(43):22793-22805. Epub 2016 Sep 2.

30.

Phosphorylation of CDC25A on SER283 in late S/G2 by CDK/cyclin complexes accelerates mitotic entry.

Mazzolini L, Broban A, Froment C, Burlet-Schiltz O, Besson A, Manenti S, Dozier C.

Cell Cycle. 2016 Oct 17;15(20):2742-52. doi: 10.1080/15384101.2016.1220455. Epub 2016 Aug 11.

31.

Eph-mediated tyrosine phosphorylation of citron kinase controls abscission.

Jungas T, Perchey RT, Fawal M, Callot C, Froment C, Burlet-Schiltz O, Besson A, Davy A.

J Cell Biol. 2016 Aug 29;214(5):555-69. doi: 10.1083/jcb.201602057. Epub 2016 Aug 22.

32.

Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation.

Voisinne G, García-Blesa A, Chaoui K, Fiore F, Bergot E, Girard L, Malissen M, Burlet-Schiltz O, Gonzalez de Peredo A, Malissen B, Roncagalli R.

Mol Syst Biol. 2016 Jul 29;12(7):876. doi: 10.15252/msb.20166837.

33.

Adipocyte Exosomes Promote Melanoma Aggressiveness through Fatty Acid Oxidation: A Novel Mechanism Linking Obesity and Cancer.

Lazar I, Clement E, Dauvillier S, Milhas D, Ducoux-Petit M, LeGonidec S, Moro C, Soldan V, Dalle S, Balor S, Golzio M, Burlet-Schiltz O, Valet P, Muller C, Nieto L.

Cancer Res. 2016 Jul 15;76(14):4051-7. doi: 10.1158/0008-5472.CAN-16-0651. Epub 2016 May 23.

34.

Themis1 enhances T cell receptor signaling during thymocyte development by promoting Vav1 activity and Grb2 stability.

Zvezdova E, Mikolajczak J, Garreau A, Marcellin M, Rigal L, Lee J, Choi S, Blaize G, Argenty J, Familiades J, Li L, Gonzalez de Peredo A, Burlet-Schiltz O, Love PE, Lesourne R.

Sci Signal. 2016 May 17;9(428):ra51. doi: 10.1126/scisignal.aad1576.

PMID:
27188442
35.

LYR3, a high-affinity LCO-binding protein of Medicago truncatula, interacts with LYK3, a key symbiotic receptor.

Fliegmann J, Jauneau A, Pichereaux C, Rosenberg C, Gasciolli V, Timmers AC, Burlet-Schiltz O, Cullimore J, Bono JJ.

FEBS Lett. 2016 May;590(10):1477-87. doi: 10.1002/1873-3468.12191. Epub 2016 May 17.

36.

Spiked proteomic standard dataset for testing label-free quantitative software and statistical methods.

Ramus C, Hovasse A, Marcellin M, Hesse AM, Mouton-Barbosa E, Bouyssié D, Vaca S, Carapito C, Chaoui K, Bruley C, Garin J, Cianférani S, Ferro M, Dorssaeler AV, Burlet-Schiltz O, Schaeffer C, Couté Y, Gonzalez de Peredo A.

Data Brief. 2015 Dec 17;6:286-94. doi: 10.1016/j.dib.2015.11.063. eCollection 2016 Mar.

37.

Clinical implications of recent advances in proteogenomics.

Locard-Paulet M, Pible O, Gonzalez de Peredo A, Alpha-Bazin B, Almunia C, Burlet-Schiltz O, Armengaud J.

Expert Rev Proteomics. 2016;13(2):185-99. doi: 10.1586/14789450.2016.1132169. Epub 2016 Jan 13.

PMID:
26654119
38.

Benchmarking quantitative label-free LC-MS data processing workflows using a complex spiked proteomic standard dataset.

Ramus C, Hovasse A, Marcellin M, Hesse AM, Mouton-Barbosa E, Bouyssié D, Vaca S, Carapito C, Chaoui K, Bruley C, Garin J, Cianférani S, Ferro M, Van Dorssaeler A, Burlet-Schiltz O, Schaeffer C, Couté Y, Gonzalez de Peredo A.

J Proteomics. 2016 Jan 30;132:51-62. doi: 10.1016/j.jprot.2015.11.011. Epub 2015 Nov 14.

PMID:
26585461
39.

Substrates of the ASB2α E3 ubiquitin ligase in dendritic cells.

Spinner CA, Uttenweiler-Joseph S, Metais A, Stella A, Burlet-Schiltz O, Moog-Lutz C, Lamsoul I, Lutz PG.

Sci Rep. 2015 Nov 5;5:16269. doi: 10.1038/srep16269.

40.

Revisiting the Timing of Action of the PAG Adaptor Using Quantitative Proteomics Analysis of Primary T Cells.

Reginald K, Chaoui K, Roncagalli R, Beau M, Goncalves Menoita M, Monsarrat B, Burlet-Schiltz O, Malissen M, Gonzalez de Peredo A, Malissen B.

J Immunol. 2015 Dec 1;195(11):5472-81. doi: 10.4049/jimmunol.1501300. Epub 2015 Oct 28.

41.

Promoter-Dependent Translation Controlled by p54nrb and hnRNPM during Myoblast Differentiation.

Ainaoui N, Hantelys F, Renaud-Gabardos E, Bunel M, Lopez F, Pujol F, Planes R, Bahraoui E, Pichereaux C, Burlet-Schiltz O, Parini A, Garmy-Susini B, Prats AC.

PLoS One. 2015 Sep 2;10(9):e0136466. doi: 10.1371/journal.pone.0136466. eCollection 2015.

42.

Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor.

Moulédous L, Froment C, Burlet-Schiltz O, Schulz S, Mollereau C.

FEBS Lett. 2015 Aug 19;589(18):2401-8. doi: 10.1016/j.febslet.2015.07.025. Epub 2015 Jul 29.

43.

Computational and Mass-Spectrometry-Based Workflow for the Discovery and Validation of Missing Human Proteins: Application to Chromosomes 2 and 14.

Carapito C, Lane L, Benama M, Opsomer A, Mouton-Barbosa E, Garrigues L, Gonzalez de Peredo A, Burel A, Bruley C, Gateau A, Bouyssié D, Jaquinod M, Cianferani S, Burlet-Schiltz O, Van Dorsselaer A, Garin J, Vandenbrouck Y.

J Proteome Res. 2015 Sep 4;14(9):3621-34. doi: 10.1021/pr5010345. Epub 2015 Jul 22.

PMID:
26132440
44.

Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.

Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S, Burlet-Schiltz O, Larue L, Muller C, Nieto L.

Pigment Cell Melanoma Res. 2015 Jul;28(4):464-75. doi: 10.1111/pcmr.12380. Epub 2015 May 30.

PMID:
25950383
45.

TOM1 is a PI5P effector involved in the regulation of endosomal maturation.

Boal F, Mansour R, Gayral M, Saland E, Chicanne G, Xuereb JM, Marcellin M, Burlet-Schiltz O, Sansonetti PJ, Payrastre B, Tronchère H.

J Cell Sci. 2015 Feb 15;128(4):815-27. doi: 10.1242/jcs.166314. Epub 2015 Jan 14.

46.

Deciphering preferential interactions within supramolecular protein complexes: the proteasome case.

Fabre B, Lambour T, Garrigues L, Amalric F, Vigneron N, Menneteau T, Stella A, Monsarrat B, Van den Eynde B, Burlet-Schiltz O, Bousquet-Dubouch MP.

Mol Syst Biol. 2015 Jan 5;11(1):771. doi: 10.15252/msb.20145497.

47.

mzDB: a file format using multiple indexing strategies for the efficient analysis of large LC-MS/MS and SWATH-MS data sets.

Bouyssié D, Dubois M, Nasso S, Gonzalez de Peredo A, Burlet-Schiltz O, Aebersold R, Monsarrat B.

Mol Cell Proteomics. 2015 Mar;14(3):771-81. doi: 10.1074/mcp.O114.039115. Epub 2014 Dec 11.

48.

Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor.

Bray L, Froment C, Pardo P, Candotto C, Burlet-Schiltz O, Zajac JM, Mollereau C, Moulédous L.

J Biol Chem. 2014 Dec 5;289(49):33754-66. doi: 10.1074/jbc.M114.612614. Epub 2014 Oct 17.

49.

Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.

Lacroix C, Caubet C, Gonzalez-de-Peredo A, Breuil B, Bouyssié D, Stella A, Garrigues L, Le Gall C, Raevel A, Massoubre A, Klein J, Decramer S, Sabourdy F, Bandin F, Burlet-Schiltz O, Monsarrat B, Schanstra JP, Bascands JL.

Mol Cell Proteomics. 2014 Dec;13(12):3421-34. doi: 10.1074/mcp.M114.040121. Epub 2014 Sep 9.

50.

SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.

Hoedt E, Chaoui K, Huvent I, Mariller C, Monsarrat B, Burlet-Schiltz O, Pierce A.

PLoS One. 2014 Aug 12;9(8):e104563. doi: 10.1371/journal.pone.0104563. eCollection 2014.

Supplemental Content

Loading ...
Support Center